S.Amdt. 3068Senate111th Congress (2009-2011)2nd degree
S.Amdt. 3068
Sponsored by
Sen. Jon Kyl (R-AZ)
Submitted December 8, 2009
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
December 8, 2009
Text
Submitted
SA 3068. Mr. KYL (for himself, Mr. Roberts, Mr. Vitter, Mr. Grassley, Mr. Crapo, Mr. Coburn, Mr. Barrasso, and Mr. Johanns) submitted an amendment intended to be proposed to amendment SA 2786 proposed by Mr. Reid (for himself, Mr. Baucus, Mr. Dodd, and Mr. Harkin) to the bill H.R. 3590, to amend the Internal Revenue Code of 1986 to modify the first-time homebuyers credit in the case of members of the Armed Forces and certain other Federal employees, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. __. PROHIBITION ON CERTAIN USES OF DATA OBTAINED FROM COMPARATIVE EFFECTIVENESS RESEARCH; ACCOUNTING FOR PERSONALIZED MEDICINE AND DIFFERENCES IN PATIENT TREATMENT RESPONSE. (a) In General.--Notwithstanding any other provision of law, a Federal department, office, or representative-- (1) shall not use data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5), to deny coverage of an item or service under a Federal health care program (as defined in section 1128B(f) of the Social Security Act (42 U.S.C. 1320a-7b(f))), including under plans offered under the Federal Employees Health Benefits Program (under chapter 89 of title 5, United States Code), or under private health insurance; and (2) shall ensure that comparative effectiveness research conducted or supported by the Federal Government accounts for factors contributing to differences in the treatment response and treatment preferences of patients, including patient- reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits. (b) Rule of Construction.--Nothing in this section shall be construed as affecting the authority of the Commissioner of Food and Drugs under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act. (c) Patient Centered Outcomes Research Institute Board.-- Notwithstanding section 1181(f)(1)(A) and (B) of the Social Security Act (as added by section 6301(a)), no Federal officer or employee (including Federally elected officials and members of Congress) shall serve on the Board of Governors of the Patient Centered Outcomes Research Institute. ______